Revenio Group (REG1V.HE) Stock Analysis & AI Equity Report

Medical - Equipment & Services EUR Explore free reports

Revenio Group (REG1V.HE) overview

Revenio Group (REG1V.HE) stock analysis and AI equity research. For the latest completed financial year, 2025, Revenio Group reported revenue of EUR 110m and operating profit of EUR 25.4m; the year-end share price was 22.40 EUR and market capitalisation was EUR 595m. Revenio Group is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Revenio Group's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueEUR 115mFY 2025
Share price22.40 EURFY 2025 year end
RevenueEUR 110mFY 2025
Operating profitEUR 25.4mFY 2025
Net earningsEUR 17.4mFY 2025
Market capitalisationEUR 595mFY 2025 year end

Figures updated on 2026-07-27. Data will be refreshed during report generation.

About Revenio Group

Revenio Group is a global provider of eye care diagnostic and vision care technology. It sells tonometers, retinal imaging devices, perimeters, OCT and refraction systems, plus clinical software under the iCare and Visionix brands. The company serves optometry, optical retail and ophthalmology, and in 2026 expanded through the acquisition of Visionix.

Generate the Revenio Group report

Revenio Group is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Revenio Group and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Revenio Group

Each is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by what other analysts said the work added over the engine's report — a score out of five from people who had to read it to give it.